Songtao Cheng

435 total citations
16 papers, 300 citations indexed

About

Songtao Cheng is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Songtao Cheng has authored 16 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in Songtao Cheng's work include Peroxisome Proliferator-Activated Receptors (5 papers), Cancer, Lipids, and Metabolism (4 papers) and Ferroptosis and cancer prognosis (3 papers). Songtao Cheng is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (5 papers), Cancer, Lipids, and Metabolism (4 papers) and Ferroptosis and cancer prognosis (3 papers). Songtao Cheng collaborates with scholars based in China, United States and France. Songtao Cheng's co-authors include Gang Wang, Yu Xiao, Kaiyu Qian, Xinghuan Wang, Xuefeng Liu, Lingao Ju, Yejinpeng Wang, Liwei Cai, Yaoyi Xiong and Rui Cao and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and ACS Applied Materials & Interfaces.

In The Last Decade

Songtao Cheng

16 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Songtao Cheng China 9 172 124 68 56 34 16 300
Christine Yim‐Ping Wong Hong Kong 11 252 1.5× 163 1.3× 65 1.0× 56 1.0× 55 1.6× 18 388
Kun-Zhe Wu China 13 160 0.9× 118 1.0× 68 1.0× 47 0.8× 70 2.1× 19 319
Austin Yeon United States 10 197 1.1× 126 1.0× 58 0.9× 60 1.1× 38 1.1× 17 321
Jielin Yan United States 6 238 1.4× 94 0.8× 42 0.6× 30 0.5× 37 1.1× 10 324
Kai Zeng China 9 116 0.7× 116 0.9× 69 1.0× 45 0.8× 71 2.1× 24 266
Kun Zhou China 11 197 1.1× 189 1.5× 47 0.7× 38 0.7× 53 1.6× 26 356
Qinhua Xi China 9 153 0.9× 122 1.0× 108 1.6× 36 0.6× 58 1.7× 19 317
Jinzhe Zhou China 11 147 0.9× 94 0.8× 44 0.6× 39 0.7× 43 1.3× 21 255
Nico Hinz Germany 6 209 1.2× 66 0.5× 53 0.8× 48 0.9× 82 2.4× 20 339
Tonggang Qi China 13 188 1.1× 80 0.6× 46 0.7× 34 0.6× 58 1.7× 21 347

Countries citing papers authored by Songtao Cheng

Since Specialization
Citations

This map shows the geographic impact of Songtao Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Songtao Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Songtao Cheng more than expected).

Fields of papers citing papers by Songtao Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Songtao Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Songtao Cheng. The network helps show where Songtao Cheng may publish in the future.

Co-authorship network of co-authors of Songtao Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Songtao Cheng. A scholar is included among the top collaborators of Songtao Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Songtao Cheng. Songtao Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Song, Fei, et al.. (2025). A systematic analysis of temporal trends, characteristics, and citations of retracted stem cell publications. BMC Medicine. 23(1). 131–131. 2 indexed citations
2.
Cheng, Songtao, Gang Huang, Ziqiang Zhang, et al.. (2025). Mono-Dispersed Ultra-Long Single-Walled Carbon Nanotubes Enable the Tough, Binder-Free, and Self-Supporting TiNb2O7 Thick Electrode for High-Rate Li-Ion Battery. ACS Applied Materials & Interfaces. 17(29). 41923–41935. 1 indexed citations
3.
Yan, Xiaomin, Di Lu, Haiqi Wang, et al.. (2025). Glycan Covalent Targeting Chimera‐Based T‐Cell Glycoengineering for Boosting Immunotherapy. Chemistry - A European Journal. 31(30). e202500364–e202500364. 1 indexed citations
4.
Jia, Runda, et al.. (2023). Robust coordinated optimization of the thickening-dewatering process under uncertain feeding conditions. Process Safety and Environmental Protection. 202. 103–114. 1 indexed citations
5.
Zhong, Yihong, Le Xu, Yuna Guo, et al.. (2023). Site-selected in situ polymerization for living cell surface engineering. Nature Communications. 14(1). 7285–7285. 23 indexed citations
6.
7.
Zhou, Fenfang, Yaoyi Xiong, Songtao Cheng, et al.. (2021). CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma. Frontiers in Oncology. 10. 570819–570819. 20 indexed citations
8.
Wang, Gang, Songtao Cheng, Yaoyi Xiong, et al.. (2020). The role and function of PPARγ in bladder cancer. Journal of Cancer. 11(13). 3965–3975. 20 indexed citations
9.
Wang, Gang, Rui Cao, Kaiyu Qian, et al.. (2020). <p>TRPM8 Inhibition Regulates the Proliferation, Migration and ROS Metabolism of Bladder Cancer Cells</p>. OncoTargets and Therapy. Volume 13. 8825–8835. 16 indexed citations
10.
Cheng, Songtao, Xiaolu Zhu, Fenfang Zhou, et al.. (2020). BORA regulates cell proliferation and migration in bladder cancer. Cancer Cell International. 20(1). 290–290. 5 indexed citations
11.
Liu, Wei, Lingao Ju, Songtao Cheng, et al.. (2020). Conditional reprogramming: Modeling urological cancer and translation to clinics. SHILAP Revista de lepidopterología. 10(2). e95–e95. 13 indexed citations
12.
13.
Cheng, Songtao, Kaiyu Qian, Yejinpeng Wang, et al.. (2019). PPARγ inhibition regulates the cell cycle, proliferation and motility of bladder cancer cells. Journal of Cellular and Molecular Medicine. 23(5). 3724–3736. 43 indexed citations
14.
Cheng, Songtao, Gang Wang, Yejinpeng Wang, et al.. (2019). Fatty acid oxidation inhibitor etomoxir suppresses tumor progression and induces cell cycle arrest via PPARγ-mediated pathway in bladder cancer. Clinical Science. 133(15). 1745–1758. 91 indexed citations
15.
16.
Wang, Yejinpeng, Chen Liang, Gang Wang, et al.. (2018). Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis. Journal of Cellular Physiology. 234(7). 10225–10237. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christine Yim‐Ping Wong Breakdown of academic impact, for papers by Kun-Zhe Wu Breakdown of academic impact, for papers by Austin Yeon Breakdown of academic impact, for papers by Jielin Yan Breakdown of academic impact, for papers by Kai Zeng Breakdown of academic impact, for papers by Kun Zhou Breakdown of academic impact, for papers by Qinhua Xi Breakdown of academic impact, for papers by Jinzhe Zhou Breakdown of academic impact, for papers by Nico Hinz Breakdown of academic impact, for papers by Tonggang Qi
Rankless by CCL
2026